Ensysce Biosciences Inc (NASDAQ:ENSC) currently has a daily average trading volume of 13.75M but it saw 6547248 shares traded in last market. With a market cap of 4.70M USD, the company’s current market price of $0.31 came falling about -21.49 while comparing to the previous closing price of $0.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.06 and as low as $0.14. In the recent trading on the day, stock has struck highest price mark of $0.31 while lowest mark touched by it was $0.3773.
Taking a look at 20-day trading activity of Ensysce Biosciences Inc (ENSC) gives us an average price of $0.2363, while its current price level is -84.71% below from 52-week high level whereas it is 123.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3221 while that of 200 days or SMA-200 reads an average of $0.6298. A closer look into the stock’s movement over the week reveals that its volatility is standing at 33.80% during that period while stretching the period over a month that decreases to 17.05%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 53.29 which implies that the stock is in neutral territory.
Over the week, ENSC’s stock price is moving 75.68% up while it is 5.70% when we observe its performance for the past one month. Year-to-date it is -70.28% down and over the past year, the stock is showing a downside performance of -73.31%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.87 beat the consensus estimate of -1.06 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.29 while estimate for next year EPS is -1.43. Moreover, analysts are in estimates of $250k for current-quarter revenue.
Currently, Ensysce Biosciences Inc’s total number of outstanding shares is 14.91M. Company’s return on investment (ROI) stands at -623.85% and return on equity (ROE) at -380.55%. Stock’s beta reads 0.82. Stock has a price to book (P/B) ratio of 1.42 while price to sale or P/S ratio amounts to 3.26. Its return on asset (ROA) is -246.41% on average.
